Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
$7.81
$7.81
$4.06
$9.16
N/AN/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
$25.80
+0.0%
$25.80
$24.39
$27.81
$2.58MN/A515 shs100 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
0.00%0.00%0.00%0.00%0.00%
MCRO
IQ Hedge Macro Tracker ETF
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
0.00
N/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/A0.00N/AN/AN/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
$0.622.40%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/A
MCRO
IQ Hedge Macro Tracker ETF
N/A

Insider Ownership

CompanyInsider Ownership
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
72.90%
MCRO
IQ Hedge Macro Tracker ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
6N/AN/ANot Optionable
MCRO
IQ Hedge Macro Tracker ETF
147,000100,000N/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Top Headlines

View All Headlines
Emisphere Technologies stock logo

Emisphere Technologies OTCMKTS:EMIS

$7.81 0.00 (0.00%)
As of 12/9/2020

Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey.

IQ Hedge Macro Tracker ETF NYSEARCA:MCRO

$25.80 +0.01 (+0.04%)
As of 01/31/2023

IQ Hedge Macro Tracker ETF (the Fund) is an exchange-traded fund that seeks to track, before fees and expenses, the performance of the IQ Hedge Macro Index (the Index). The Index seeks to replicate the risk-adjusted return characteristics of hedge funds that employ various hedge fund investment styles, which may include but are not limited to long/short equity, macro, market neutral, event-driven, fixed-income arbitrage, emerging markets and other strategies commonly used by hedge fund managers (the Strategy). The Fund is a fund of funds as each invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its Index, which includes underlying funds. The Fund's investment advisor is IndexIQ Advisors LLC and its sub-advisor is Mellon Capital Management Corporation.